Ratings by H.C. Wainwright (Oren Livnat)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/23/2025 | Avadel Pharmaceuticals | AVDL | Downgrade | Neutral (Buy) |
18.52 (21.64) |
16.85% | Details | |
| 9/5/2025 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2025 | Verrica Pharmaceuticals | VRCA | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/8/2025 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2025 | Collegium Pharmaceutical | COLL | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2025 | Grace Therapeutics | GRCE | Maintain | Buy (Buy) |
|
Details | ||
| 11/15/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | ANI Pharmaceuticals | ANIP | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2024 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2024 | Verrica Pharmaceuticals | VRCA | Downgrade | Neutral (Buy) |
0.80 (6.06) |
657.5% | Details | |
| 10/22/2024 | Trevi Therapeutics | TRVI | Maintain | Buy (Buy) |
|
Details | ||
| 10/21/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (Buy) |
|
Details | ||
| 9/26/2024 | Acasti Pharma | ACST | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2024 | ANI Pharmaceuticals | ANIP | Maintain | Buy (Buy) |
|
Details | ||
| 9/5/2024 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2024 | Collegium Pharmaceutical | COLL | Upgrade | Buy (Neutral) |
34.89 (34.93) |
0.11% | Details | |
| 7/10/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (Buy) |
|
Details | ||
| 7/3/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2024 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2024 | Cara Therapeutics | CARA | Downgrade | Neutral (Buy) |
0.68 (5.32) |
682.35% | Details | |
| 5/14/2024 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2023 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2023 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2023 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2023 | Acasti Pharma | ACST | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Agile Therapeutics | AGRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Satsuma Pharmaceuticals | STSA | Downgrade | Neutral (Buy) |
1.08 (1.10) |
1.85% | Details | |
| 3/23/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | ANI Pharmaceuticals | ANIP | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2022 | Agile Therapeutics | AGRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2022 | Acasti Pharma | ACST | New Coverage | Buy (N/A) |
0.35 (3.37) |
862.86% | Details | |
| 9/21/2022 | Satsuma Pharmaceuticals | STSA | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2022 | ANI Pharmaceuticals | ANIP | New Coverage | Buy (N/A) |
34.94 (65.31) |
86.92% | Details | |
| 8/8/2022 | Collegium Pharmaceutical | COLL | Downgrade | Neutral (Buy) |
20.10 (36.59) |
82.04% | Details | |
| 8/5/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Otonomy | OTIC | Downgrade | Neutral (Buy) |
0.29 (0.08) |
-72.41% | Details | |
| 5/31/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | Antares Pharma | ATRS | Downgrade | Neutral (Buy) |
5.58 (5.59) |
0.18% | Details | |
| 3/3/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2022 | BioDelivery Sciences International | BDSI | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2022 | Kempharm | KMPH | Upgrade | Buy (Neutral) |
6.44 (5.81) |
-9.78% | Details | |
| 12/31/2021 | Xeris Pharmaceuticals | XERS | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2021 | BioDelivery Sciences International | BDSI | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2021 | Tarsus Pharmaceuticals | TARS | New Coverage | Buy (N/A) |
24.13 (42.98) |
78.12% | Details | |
| 11/5/2021 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | BioDelivery Sciences International | BDSI | Downgrade | Neutral (Buy) |
3.96 (5.59) |
41.16% | Details | |
| 10/29/2021 | Xeris Pharmaceuticals | XERS | New Coverage | Buy (N/A) |
1.80 (7.69) |
327.22% | Details | |
| 8/16/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2021 | Taiwan Liposome Co Ltd. | TLC | Downgrade | Neutral (Buy) |
6.80 (7.00) |
2.94% | Details | |
| 6/21/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Novan | NOVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Antares Pharma | ATRS | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | BioDelivery Sciences International | BDSI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Kempharm | KMPH | Downgrade | Neutral (Buy) |
13.47 (5.81) |
-56.87% | Details | |
| 3/2/2021 | Satsuma Pharmaceuticals | STSA | Maintain | Neutral (N/A) |
|
Details | ||
| 12/28/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 12/24/2020 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Verrica Pharmaceuticals | VRCA | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
7.94 (18.52) |
133.25% | Details | |
| 6/1/2020 | Menlo Therapeutics | MNLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2020 | Lipocine Inc | LPCN | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2020 | Kempharm | KMPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Menlo Therapeutics | MNLO | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2020 | Agile Therapeutics | AGRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Menlo Therapeutics | MNLO | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2020 | Agile Therapeutics | AGRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2020 | Taiwan Liposome Co Ltd. | TLC | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2019 | Menlo Therapeutics | MNLO | New Coverage | Buy (N/A) |
4.58 (1.35) |
-70.52% | Details | |
| 8/29/2019 | Otonomy | OTIC | New Coverage | Buy (N/A) |
2.16 (0.08) |
-96.3% | Details | |
| 8/12/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | Lipocine Inc | LPCN | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Verrica Pharmaceuticals | VRCA | New Coverage | Buy (N/A) |
11.09 (6.84) |
-38.32% | Details | |
| 10/26/2018 | Novan | NOVN | New Coverage | Buy (N/A) |
2.32 (0.09) |
-96.12% | Details | |
| 10/15/2018 | Corium International | CORI | Downgrade | Neutral (Buy) |
8.31 (103.12) |
1140.91% | Details | |
| 8/17/2018 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2018 | Antares Pharma | ATRS | Maintain | Buy (N/A) |
|
Details |
